Medication Compliance Initiatives in the Workplace
February 18th 2010Almost 90% of employers consider employee medication compliance to be a prime health management objective, according to a study by the National Pharmaceutical Council (NPC).1 The majority of study respondents reported that they are analyzing or have plans to analyze prescription data to determine medication compliance for select health conditions.
2009 H1N1 Influenza: Antiviral Use for Prevention and Treatment
February 18th 2010This discussion reviews the currently available antivirals and recommendations for their use in influenza prophylaxis and treatment. Because our understanding of 2009 H1N1 influenza is still evolving, some off-label use of medications is discussed and noted. Information on 2009 H1N1 is updated frequently, andreaders are encouraged to monitor advisories from federal, state, and local health agencies for up-to-date information. (Drug Benefit Trends. 2010;22:10-14)
More Recovery Act Dollars Awarded to Buoy Up Community Health Centers
February 18th 2010Nearly $600 million from the American Recovery and Reinvestment Act (Recovery Act) was awarded to 85 federally qualified community health centers to support major construction and renovation projects and help adopt electronic health record and other health information
Medicare to Cover HIV Screening Tests
February 18th 2010The list of covered preventive services for Medicare beneficiaries has expanded to include screening for HIV infection, according to the Centers for Medicare and Medicaid Services. This test will now be available to Medicare beneficiaries at increased risk for HIV infection, including women who are pregnant and any Medicare beneficiary of any age who requests testing.1
Diabetes Drugs Fell in the Doughnut Hole
February 18th 2010The gap in Medicare prescription drug coverage, or the doughnut hole, may be why many seniors with diabetes are not adhering to medications. Researchers from Kaiser Permanente and the David Geffen School of Medicine at the University of California, Los Angeles, focused their study on what happens during the gap, or when patients are paying for their medications out of pocket.1
Health care spending Continues to Slow
February 18th 2010Health care spending in the United States slowed to a growth rate of 4.4% in 2008-the slowest in 48 years-as national health spending reached $2.3 trillion ($7681 per person). These results were published in an annual report from the National Health Expenditure Accounts Team.1
Rising Rates of Disability Among Older Adults
February 18th 2010A recent study has shown that rates of disability may be rising among noninstitutionalized adults 65 years and older in the United States.1 “People are living longer, but many are also living sicker,” said Amani Nuru-Jeter, PhD, MPH, assistant professor of community health and human development at the University of California Berkeley School of Public Health, and coauthor of the study.
Electronic Medical Records: Functionality Misses the Mark in Coordination of Care
February 18th 2010Although policymakers continue to push for greater adoption of electronic medical records (EMRs), physicians already using these systems report difficulty in exchanging data because of program interoperability, according to a new report.1 “We found that many aspects of the EMRs are helpful for coordination of care delivered within the physician’s office,” said Ann S. O’Malley, MD, MPH, lead study author and senior researcher at the Center for Studying Health System Change, in an interview with Drug Benefit Trends. “But there are areas for both office care processes and EMR design to evolve in order for EMRs to better support coordination tasks.”
Cephalosporins: How to Minimize the Risk of Neurotoxicity
February 16th 2010Cephalosporins are usually considered relatively safe antibiotics; however, serious neurological adverse effects can occur following administration.1-5 Manifestations of cephalosporin-induced neurotoxicity may include confusion, disorientation, twitching, somnolence, myoclonus, and seizures, particularly in patients with reduced renal function.6,7 Here we discuss the mechanism, risk factors, and management of cephalosporin-induced neurotoxicity.